Michigan State University Survey on Meso
Michigan State University researchers are looking for study participants to better understand the experiences and challenges unique to caregivers of mesothelioma patients, so we can
New Mesothelioma Publication by our REP Haining Yang: Molecular Determinants of Immunotherapy Efficacy in Mesothelioma: A Step Toward Precision Oncology
Read more here: https://www.jto.org/article/S1556-0864(25)01013-5/fulltext
New Publication by Dr. Testa and Dr. Kadariya: Spontaneous mesotheliomas in germline Bap1 heterozygous mice from different genetic backgrounds
Individuals carrying a germline BAP1 mutation are at increased risk of developing mesothelioma. In mice, there is limited information and controversy regarding whether germline Bap1
Contribute to “Emerging Trends in Malignant Mesothelioma”
Contribute to “Emerging Trends in Malignant Mesothelioma”: A special Biomedicines issue by Guest Editor Yuan Xu Yuan Xu, guest editor from Baylor University, will complete
Haining Yang
Dr. Haining Yang is a tenured professor and researcher at the University of Hawai‘i Cancer Center, recognized for her pioneering research on mesothelioma, a malignancy
Siena Martin
Siena Martin is a research specialist at the University of Pennsylvania Tumor Tissue and Biospecimen Bank (TTAB) and serves as a liaison and member of
Check out the MARF 2024 Symposium Livestream!
If you missed the MARF 2024 Symposium, you can catch a livestream of it here! https://www.curemeso.org/learn/attend-conferences-and-events/symposium/watch-conference-live-stream-and-chat/
2024 Grant Cycle Now Open at MARF
MARF is pleased to announce that the 2024 research funding grant cycle is now open and accepting pre-application letters of intent (LOI) until 11:59 PM ET Sunday,
New TMA Page
The newest addition to the website is the TMA page! You can now get a look at what cases are available for each our TMAs.